Аннотация:
Aim. Analysis of the treatment response rates of different therapy regimens of functional constipation, including Ipidacrine, a cholinesterase inhibitor, based on assessment of adaptation and compensatory mechanisms in the therapy forecast. Materials and methods. 77 functional slow-transit constipation patients were examined after therapy regimens of functional constipation, the mean age is 44.30±14.58 y.o. Results and discussion. The treatment response rates of different therapies with Ipidacrine depends on the patient's initial adaptation and compensatory mechanisms (ACM index); certain aspects allowing to predict the expected result depending on the current mental state were identified; the severity of the state of functional constipation, ACM index and MMPI test psychometric indicators are correlated; adaptation and compensatory mechanisms of functional constipation patients were found to be reduced; the prognosis of the treatment response rates and, accordingly, the choice of the
Ключевые слова:
Adaptation mechanisms; Functional slow-transit constipation; Ipidacrine; Psychological resources; Stress
aminoquinoline derivative; amiridine; adult; constipation; gastrointestinal transit; human; middle aged; multimodality cancer therapy; prognosis; Adult; Aminoquinolines; Combined Modality Therapy; Constipation; Gastrointestinal Transit; Humans; Middle Aged; Prognosis
Чернусь Н. П. Наталья Павловна 1956-
Ванчакова Н. П.
Сивкова С. К. Светлана Константиновна 1950-
Сивков А. С. Андрей Сергеевич 1973-
Горенков Р. В. Роман Викторович 1966-
Chernus` N. P. Natal`ya Pavlovna 1956-
Vanchakova N. P.
Sivkova S. K. Svetlana Konstantinovna 1950-
Sivkov A. S. Andrej Sergeevich 1973-
Gorenkov R. V. Roman Viktorovich 1966-
Ipidacrine in combination therapy regimens of functional constipation [Ипидакрин в комбинированных схемах лечения функционального запора]
Текст визуальный непосредственный
Терапевтический архив
Медицинское маркетинговое агентство "МедиаМедика"
Т. 90, Вып. 12 С. 48-55
2018
Статья
Adaptation mechanisms Functional slow-transit constipation Ipidacrine Psychological resources Stress
aminoquinoline derivative amiridine adult constipation gastrointestinal transit human middle aged multimodality cancer therapy prognosis Adult Aminoquinolines Combined Modality Therapy Constipation Gastrointestinal Transit Humans Middle Aged Prognosis
Aim. Analysis of the treatment response rates of different therapy regimens of functional constipation, including Ipidacrine, a cholinesterase inhibitor, based on assessment of adaptation and compensatory mechanisms in the therapy forecast. Materials and methods. 77 functional slow-transit constipation patients were examined after therapy regimens of functional constipation, the mean age is 44.30±14.58 y.o. Results and discussion. The treatment response rates of different therapies with Ipidacrine depends on the patient's initial adaptation and compensatory mechanisms (ACM index); certain aspects allowing to predict the expected result depending on the current mental state were identified; the severity of the state of functional constipation, ACM index and MMPI test psychometric indicators are correlated; adaptation and compensatory mechanisms of functional constipation patients were found to be reduced; the prognosis of the treatment response rates and, accordingly, the choice of the